Raverot, Gérald http://orcid.org/0000-0002-9517-338X
Ilie, Mirela Diana http://orcid.org/0000-0001-7248-7258
Lasolle, Hélène
Amodru, Vincent
Trouillas, Jacqueline
Castinetti, Frédéric
Brue, Thierry http://orcid.org/0000-0001-8482-6691
Article History
Accepted: 23 July 2021
First Online: 7 September 2021
Competing interests
: G.R. received research grants and consulting fees from Ipsen, Novartis, Pfizer and Recordati Rare Diseases. F.C. received research grants and consulting fees from HRA Pharma Rare Diseases, Ipsen, Novartis, Pfizer and Recordati Rare Diseases. T.B. received consultant/speaker fees or research grants from Advanz Pharma, Corcept, Ipsen Pharma, Merck-Serono, Novartis Pharma SAS, Novo-Nordisk, Pfizer SAS, Recordati Rare Diseases, and Sandoz. The other authors declare no competing interests.